Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PRIM
10. PFE

Go back to Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
(NASDAQ: QNRX) Delayed: 4.22 -0.19 (4.31%)
Previous Close $4.41    52 Week High $ 
Open $4.20    52 Week Low $ 
Day High $5.07    P/E N/A 
Day Low $4.10    EPS $ 
Volume 620,973